scholarly article | Q13442814 |
P50 | author | Steven J Jacobsen | Q37384936 |
Reina Haque | Q88303669 | ||
P2093 | author name string | T Craig Cheetham | |
Ronald K Loo | |||
Jiaxiao M Shi | |||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1660-1664 | |
P577 | publication date | 2008-10-01 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Association between 5-alpha reductase inhibition and risk of hip fracture | |
P478 | volume | 300 |
Q43675196 | A population-based nested case-control study: the use of 5-alpha-reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia |
Q55380284 | A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride. |
Q34395346 | Androgens and estrogens in skeletal sexual dimorphism. |
Q51452748 | DHEA administration activates local bioactive androgen metabolism in cancellous site of tibia of ovariectomized rats. |
Q34556225 | Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels |
Q48970211 | Dutasteride improves bone mineral density in male patients with lower urinary tract symptoms and prostatic enlargement: a preliminary study. |
Q43842409 | Effects of dutasteride on lower urinary tract symptoms and general health in men with benign prostatic hypertroplasia and hypogonadism: a prospective study |
Q34543980 | Estrogens and Androgens in Skeletal Physiology and Pathophysiology |
Q39168087 | Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial |
Q33610301 | Male osteoporosis and androgenic therapy: from testosterone to SARMs. |
Q39042961 | Risk for Hip Fracture due to Alpha Blocker Treatment in Korean Women: National Health Insurance Database Study |
Q35808841 | Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study |
Q57153138 | Risk of fractures associated with treatment for benign prostate hyperplasia in men |
Q36243696 | Risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy among elderly males: a self-controlled case series study |
Q34437537 | Sex steroid actions in male bone |
Q28301391 | Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology |
Q36206485 | The risk of fall and fracture with the initiation of a prostate-selective α antagonist: a population based cohort study |
Search more.